Coagulation properties and Nostrano di Primiero cheese yield of milk from Brown grazing cows of different k-casein genotype

Propriet\ue0 di coagulazione e resa in Nostrano di Primiero del latte di vacche Brune al pascolo con differente genotipo per la k-caseina \u2013 Il latte prodotto in alpeggio da 16 bovine di razza Bruna Italiana con diverso genotipo per la k-caseina, 8 AA e 8 BB, \ue8 stato analizzato per composizione e caratteristiche reologiche. Lo stesso latte \ue8 stato trasformato in formaggio del tipo Nostrano di Primiero. La composizione del latte e il tempo di coagulazione (r) sono risultati simili tra i due tipi genetici, cos\uec come la composizione del siero e la resa in formaggio. Il tempo di rassodamento del coagulo (k20) e la sua consistenza (a30) sono risultati invece migliori per il tipo genetico BB rispetto all\u2019AA (4,2 min vs 7,9 min e 32,9 mm vs 25,2 mm)

Aflatoxin occurrence in goat milk and supplied concentrate feed in farms of Veneto, Trentino and Friuli Venezia Giulia

Aflatoxin M1 (AFM1) is a probable human hepatocarcinogen (IARC, monographs on the evaluation of carcinogenic risks to human. Vol. 56, 1993) found in milk of animals that consume feeds contaminated with aflatoxin B1 (AFB1), produced by fungi of genus Aspergillus. There is little information about goat milk: the aim of this study was to examine the level of contamination of milk, and related concentrate feed, in goat farms of Veneto, Trentino and Friuli Venezia Giulia. In 2005 and 2006, during the lactation period, 79 samples of total daily milk and 125 concentrate feed samples (principally maize and concentrate feeds), collected in 17 goat farms of Triveneto, were analysed for the content of AFM1 and AFB1 respectively, by HPLC technique. Concerning the milk samples, only one-third of total samples exceed the analytical reliability level (3 ppt), 14 of which were positioned under the value of 9 ppt and only 1 sample was over the value of 27 ppt.With regard to the feed samples, the two-thirds of total samples exceed the analytical reliability level (0.1 ppb), 54 of which had a value lower than 1 ppb and only 1 had a value higher than 10 ppb. The relation between levels of aflatoxin in milk and feeds was also considered: there is a significant correlation that confirms the role of feeds in the contamination of milk. All the samples had values lower than the maximum limit established by Italian law concerning the content of aflatoxins in milk for human diet and the content of aflatoxin in the concentrates for the goat diet (AFM1: 50 ppt; AFB1: 20 ppb), showing a general situation of absence of risk for animal and human health, with only few cases to keep under control. The results are in accordance with the situation found in other regions of North Italy (Regione Lombardia, 2003-2005), where, also in the dairy cow sector, there was a reduction of aflatoxin contamination risk in 2005 after two years of high levels of contamination of the maize and of the milk

Variability in the characteristics of fresh meat and thighs in relationship to genetic type of the heavy pig

The variability in the characteristics of fresh meat and thighs in relationship with genetic type was studied on 22 lots of heavy pigs, comprising 615 female and castrated males, randomly chosen during slaughtering in groups of 20 to 30 animals per lot. Four different genetic types reared for the production of the San Daniele dry-cured ham PDO were considered: two traditionals (Large White or Duroc x (Landrace x Large White) and two industrial hybrids (GOLAND and DANBRED). Fresh meat samples from longissimus dorsi muscle were collected to perform chemical and physical analysis. The right trimmed thighs were used to evaluate some morphological parameters along with weight losses during seasoning. The genetic type confirmed its important influence on pig carcass, meat and ham quality. The two industrial types, DANBRED in particular, tended to present a lower back fat values and a leaner carcass than the two Italian genetic types. Within the most important characteristics for the production of dry cured hams (subcutaneous fat thickness and seasoning losses) the highest differences were found among the industrials genetic types, which cannot be simply considered as an undifferentiated homogenous group

Genetic characterization of alpine sheep breeds

The aim of this study was to characterize from the genetic point of view eight alpine sheep breeds reared in Italy (Bergamasca, Biellese, Schwarzbraunes Bergschaf and Tiroler Bergschaf), Germany (Brillenschaf and Weisses Bergschaf) and Slovenia (Bov\u161ka and Jezerzko-Sol\u10davska) through the use of microsatellite molecular markers. Allelic richness was rather high in each breed highlighting a considerable genetic diversity. However, the study evidenced a significant departure from Hardy-Weinberg equilibrium in all analyzed breeds caused by a heterozygote deficiency. Such lack seems to be caused by a rather high level of inbreeding. The genetic differentiation among breeds was rather low (F ST = 0.064) but significant. The neighbour-joining tree obtained from Reynolds\u2019 genetic distance estimates, showed the presence of three groups formed by the three Bergschaf breeds, the Italian Bergamasca and Biellese and the two Slovenian breeds together with the German Brillenschaf. Such grouping is in accordance with the breeds\u2019 region of origin and with their known history. Concluding, microsatellite resulted to be a useful tool to investigate breed variability and to characterize alpine sheep breeds. Obtained findings suggest the need to set up a conservation plan aiming to safeguard and increase the genetic variability of the studied breeds compromised by the high level of inbreeding. Microsatellites genotyping could help to monitor breed variability and to organize matings

Understanding the Pathogenesis of Red Mark Syndrome in Rainbow Trout (Oncorhynchus mykiss) through an Integrated Morphological and Molecular Approach

Red mark syndrome is a non-lethal widespread skin disease mainly reported in rainbow trout and caused by a Midichloria-like organism. Despite extensive research, its etiology and pathogenesis are still uncertain. In the present study, the authors used an integrated morphological and molecular approach, including gene expression, to elucidate the immune response and the complex immune interaction between the host and Midichloria-like organism. The results lead to the conclusions that the most severe skin lesions were characterized by a high level of inflammatory cytokines sustaining and modulating the severe inflammatory process. In contrast, in the moderate form, the response was driven to produce immunoglobulins and IL-10 to control the severity of the disease. Humoral immunity elicited during MLO infection appeared to have a fundamental role in controlling the severity of the skin disease, possibly through bactericidal antibody-mediated mechanisms

A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease.

BACKGROUND Latrepirdine is an orally administered experimental small molecule that was initially developed as an antihistamine and subsequently was shown to stabilize mitochondrial membranes and function, which might be impaired in Huntington disease. OBJECTIVE To determine the effect of latrepirdine on cognition and global function in patients with mild to moderate Huntington disease. DESIGN Randomized, double-blind, placebo-controlled study. SETTING Sixty-four research centers in Australia, Europe, and North America. PATIENTS Four hundred three patients with mild to moderate Huntington disease and baseline cognitive impairment (Mini-Mental State Examination score, 10-26). INTERVENTION Latrepirdine (20 mg) vs matching placebo administered orally 3 times daily for 26 weeks. MAIN OUTCOME MEASURES The co-primary outcome measures were cognition as measured by the change in Mini-Mental State Examination score from baseline to week 26 and global function at week 26 as measured by the Clinician Interview-Based Impression of Change, plus carer interview, which ranges from 1 (marked improvement) to 7 (marked worsening). Secondary efficacy outcome measures included behavior, daily function, motor function, and safety. RESULTS The mean change in Mini-Mental State Examination score among participants randomized to latrepirdine (1.5-point improvement) did not differ significantly from that among participants randomized to placebo (1.3-point improvement) (P = .39). Similarly, the distribution of the Clinician Interview-Based Impression of Change, plus carer interview did not differ significantly among those randomized to latrepirdine compared with placebo (P = .84). No significant treatment effects were detected on the secondary efficacy outcome measures. The incidence of adverse events was similar between those randomized to latrepirdine (68.5%) and placebo (68.0%). CONCLUSION In patients with mild to moderate Huntington disease and cognitive impairment, treatment with latrepirdine for 6 months was safe and well tolerated but did not improve cognition or global function relative to placebo. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00920946

Benign hereditary chorea: clinical and neuroimaging features in an Italian family.

Abstract: Benign hereditary chorea is an autosomal domi- nant disorder characterized by early onset nonprogressive chorea, caused by mutations of the thyroid transcription factor-1 (TITF-1) gene. Clinical heterogeneity has been reported and thyroid and respiratory abnormalities may be present. We describe 3 patients of an Italian family carrying the S145X mutation in the TITF-1 gene with mild motor delay, childhood onset dyskinesias, and subtle cognitive impairment. A child in the third generation pre- sented with congenital hypothyroidism and neonatal respi- ratory distress. Imaging studies in 2 patients showed mild ventricular enlargement and empty sella at magnetic reso- nance imaging and hypometabolism of basal ganglia and cortex at 18-Fluoro-2-deoxy-glucose positron emission tomography

A randomized clinical trial of lithium in multiple system atrophy.

The aim of our study was to test the safety and tolerability of lithium in multiple system atrophy (MSA). The study was randomized, placebo-controlled, and double-blind. The primary endpoint of the study was safety and tolerability. An interim analysis, performed 1 year after the first patient was randomized, showed a higher proportion of trial abandon (P < 0.01) and a higher number of adverse events (P < 0.02) in the lithium group. The trial was stopped by the Data Monitoring Committee. Overall, lithium was not well tolerated, and we do not encourage future studies with lithium in MSA patients